Position history for BAILLIE GIFFORD & CO's holdings in RECURSION PHARMACEUTICALS IN
BAILLIE GIFFORD & CO holds 23.8M shares of RXRX (RECURSION PHARMACEUTICALS IN), worth $97.2M as of 2025-Q4. The position was decreased (-0.8% shares). RXRX represents 0.1% of BAILLIE GIFFORD & CO's portfolio.
Current Value
$97.2M
Current Shares
23.8M
Total Value Change
-$102.2M
Total Shares Change
-2.8M
Other major holders of RXRX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 23.8M |
-0.8% |
| $97.2M |
| 0.1% |
| $4.11 |
0 |
| 2025-Q3 | Decreased | 24M | -0.8% | $117M | 0.1% | $4.91 | 0 |
| 2025-Q2 | Decreased | 24.2M | -0.9% | $122.3M | 0.1% | $5.03 | 0 |
| 2025-Q1 | Decreased | 24.4M | -1.9% | $129M | 0.1% | $5.81 | 0 |
| 2024-Q4 | Decreased | 24.9M | -1.5% | $168.1M | 0.1% | $6.77 | 0 |
| 2024-Q3 | Decreased | 25.2M | -5.1% | $166.3M | 0.1% | $6.98 | 0 |
| 2024-Q2 | Increased | 26.6M | +10.5% | $199.4M | 0.2% | $7.50 | 40 |